Mariner, LLC Pfizer Inc Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mariner, LLC holds 1,370,237 shares of PFE stock, worth $37.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,370,237

Previous 1,342,207 2.09%

Holding current value

$37.6 Million

Previous $37.2 Million 2.93%

% of portfolio

0.08%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $708,037 - $829,688	28,030 Added 2.09%	1,370,237 $38.3 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $535,223 - $614,608	20,673 Added 1.56%	1,342,207 $37.2 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $4.14 Million - $5.38 Million	-158,500 Reduced 10.71%	1,321,534 $38 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $19.1 Million - $22.3 Million	-595,593 Reduced 28.69%	1,480,034 $49.1 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $1.41 Million - $1.63 Million	39,021 Added 1.92%	2,075,627 $76.1 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $8.33 Million - $10.8 Million	-211,401 Reduced 9.4%	2,036,606 $83.1 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $12.9 Million - $16.9 Million	309,653 Added 15.98%	2,248,007 $115 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $4.11 Million - $5.01 Million	93,867 Added 5.09%	1,938,354 $84.8 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $21.7 Million - $25.8 Million	466,952 Added 33.9%	1,844,487 $96.7 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $9.66 Million - $12 Million	211,192 Added 18.11%	1,377,535 $71.3 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $7.34 Million - $10.9 Million	177,548 Added 17.96%	1,166,343 $68.9 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $4.88 Million - $6.26 Million	124,214 Added 14.37%	988,795 $42.5 Million
Q2 2021 Aug 24, 2021	BUY	$35.91 - $40.68 $2 Million - $2.26 Million	55,612 Added 6.87%	864,581 $33.9 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $1.11 Million - $1.25 Million	33,015 Added 4.25%	808,969 $29.3 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $2.36 Million - $3 Million	70,528 Added 10.0%	775,954 $28.6 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $1.04 Million - $1.22 Million	32,810 Added 4.88%	705,426 $25.9 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $685,350 - $831,431	22,754 Added 3.5%	672,616 $22 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $1.29 Million - $1.84 Million	47,753 Added 7.93%	649,862 $21.2 Million
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $1.25 Million - $1.42 Million	37,985 Added 6.73%	602,109 $23.6 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $16.1 Million - $20.8 Million	-494,332 Reduced 46.7%	564,124 $20.3 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $137,713 - $154,620	3,724 Added 0.35%	1,058,456 $45.9 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $11.3 Million - $12.4 Million	301,527 Added 40.03%	1,054,732 $34.7 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $13.1 Million - $14.9 Million	340,506 Added 82.51%	753,205 $32.8 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $165,249 - $200,437	4,794 Added 1.18%	412,699 $18.2 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $3.73 Million - $3.97 Million	113,004 Added 38.32%	407,905 $14.8 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $19,433 - $22,545	609 Added 0.21%	294,901 $10.5 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $1.75 Million - $1.86 Million	52,655 Added 21.79%	294,292 $10.7 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $7.49 Million - $8.25 Million	241,637	241,637 $8.63 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account